Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 19 | -40 | 23 | 23 | 23 |
| Gross Profit | 19 | -40 | 23 | 23 | 23 |
| Operating Expenses | 2,689 | 3,087 | 4,948 | 6,118 | 5,519 |
| Operating Income | -2,670 | -3,128 | -4,926 | -6,095 | -5,497 |
| Interest Expense | 243 | 245 | 242 | 242 | 3,174 |
| Other Income | 140 | -128 | -69 | 2,996 | 1,682 |
| Pre-tax Income | -2,773 | -3,501 | -5,237 | -3,341 | -6,988 |
| Net Income Continuous | -2,773 | -3,501 | -5,237 | -3,341 | -6,988 |
| Net Income | $-2,773 | $-3,501 | $-5,237 | $-3,341 | $-6,988 |
| EPS Basic Total Ops | -0.23 | -0.03 | -0.49 | -0.51 | -1.30 |
| EPS Basic Continuous Ops | -0.23 | 0.02 | -0.49 | -0.51 | -1.30 |
| EPS Diluted Total Ops | -0.23 | -0.03 | -0.49 | -0.51 | -1.30 |
| EPS Diluted Continuous Ops | -0.23 | 0.02 | -0.49 | -0.51 | -1.30 |
| EBITDA(a) | $-2,328 | $-2,783 | $-4,584 | $-5,755 | $-2,285 |